Asia-Pacific Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture Assays, Other Assays), End-user (Pharmaceutical, Food And Beverages, Chemical Industry, Diagnostics, Cosmetics, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Asia-Pacific Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture Assays, Other Assays), End-user (Pharmaceutical, Food And Beverages, Chemical Industry, Diagnostics, Cosmetics, Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 5954 | Pages: 145 | October 2018 | Region: Asia Pacific


Asia Pacific Early Toxicity Testing  Market is growing at a CAGR of 8.4%, to reach USD 158.51 million by 2023. Toxicity is an extent to which a chemical substance or a particular mixture of substances can damage a living organism. During the drug development of the diseases, it has been observed that nearly 28% of the drugs are failing in the later stages of the development causing huge financial losses in the pharmaceutical, food and other industries. So, to avoid this situation, early toxicity testing is implemented in which different types of toxic tests are conducted to remove the toxic substance in the early stages reducing the risk of late stage failure.

Some of the toxicity tests include carcinogenicity, acute toxicity tests, systemic toxicity, neurotoxicity and others. All these tests are performed in in-vivo, in-vitro or in-silico techniques. In-vivo toxicity testing is done on the living animals whereas in-vitro technique testing is performed in the laboratories using biochemical assays. In-silico technique testing includes the data analysis on the computer with the help of data mining and modelling tools. This toxicity tests can easily prove to the regulatory bodies that they are extremely safe to the human health without causing any adverse effects in the future.

The primary factor driving the Asia-Pacific early toxicity testing market is early toxicity tests helps in the decrease the risk of drug failure in the later stages of the disease. Other factors include increased investment in the R&D of toxic tests to develop new cell assays methods, growing awareness of the regulatory authorities, rise in the demand for early toxicity testing, technology advancements in the biotechnology and the favourable government funding in the biotech sector. However, side-effects like skin irritation, lack of awareness about toxicity and stringent government rules will hamper the market growth.

The Asia-Pacific Early Toxicity Testing Market is segmented on the basis of technique, assays, end-user and region. Depending on the technique, the market is segmented into In-vitro, In-vivo and In-Silico. In-vitro technique is further segmented into carcinogenicity, dermal toxicity, skin sensitization and irritation, systemic toxicity, ocular toxicity, neurotoxicity, organ toxicity, genotoxicity, and others. On the basis of assays, the market is segmented into cell-based ELISA and western blots, enzyme toxicity assays, receptor binding assays, bacterial toxicity assays, tissues culture assays and others. Based on the end-user, the market is segmented into pharmaceutical, food and beverages, chemical industry, diagnostics, cosmetics and others. The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is expected to have the highest CAGR in the coming years owing to the rise in disposable income and growing demographics.

Major companies in the Asia-Pacific Early Toxicity Testing Market are Covance, Thermo Fisher Scientifics, Quest Diagnostics Corporation, Agilent Technologies, Sigma Aldrich, BD Biosciences, Bio-Rad, Gene Logic, Accelrys and Charles River Laboratories. 

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technique                   

                                5.1.1 Introduction           

                                5.1.2 In-vitro     

                                5.1.3 In-vivo      

                                5.1.4 In-Silico     

                                5.1.5  Y-o-Y Growth Analysis, By Technique         

                                5.1.6  Market Attractiveness Analysis, By Technique       

                                5.1.7  Market Share Analysis, By Technique         

                5.2 Assays                          

                                5.2.1 Introduction           

                                5.2.2 Cell-Based ELISA and Western Blots             

                                5.2.3 Enzyme Toxicity Assays     

                                5.2.4 Receptor Binding Assays   

                                5.2.5 Bacterial Toxicity Assays    

                                5.2.6 Tissues Culture Assays       

                                5.2.7 Other Assays          

                                5.2.8 Y-o-Y Growth Analysis, By Assays  

                                5.2.9 Market Attractiveness Analysis, By Assays

                                5.2.10 Market Share Analysis, By Assays               

                5.3 End-user                      

                                5.3.1 Introduction           

                                5.3.2 Pharmaceutical     

                                5.3.3 Food and Beverages           

                                5.3.4 Chemical Industry

                                5.3.5  Diagnostics             

                                5.3.6 Cosmetics

                                5.3.7 Others      

                                5.3.8 Y-o-Y Growth Analysis, By End-user             

                                5.3.9 Market Attractiveness Analysis, By End-user           

                                5.3.10 Market Share Analysis, By End-user          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technique

                                                6.1.3.3 By Assays

                                                6.1.3.4 By End-user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technique

                                                6.1.4.3 By Assays

                                                6.1.4.4 By End-user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technique

                                                6.1.5.3 By Assays

                                                6.1.5.4 By End-user

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Covance                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific                        

                8.3 Quest Diagnostics Corporation                           

                8.4 Agilent Technologies                              

                8.5 Sigma Aldrich                             

                8.6 BD Biosciences                          

                8.7 Bio-Rad                        

                8.8 Gene Logic                  

                8.9 Accelrys                       

                8.10 Charles River Laboratories                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms   Toxicity Assays, Receptor Binding Assays along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  2. Asia Pacific In-vitro Market By Region, From 2018-2023 ( USD Million )
  3. Asia Pacific In-vivo Market By Region, From 2018-2023 ( USD Million )
  4. Asia Pacific In-Silico Market By Region, From 2018-2023 ( USD Million )
  5. Asia Pacific Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  6. Asia Pacific Cell-Based ELISA and Western Blots Market By Region, From 2018-2023 ( USD Million )
  7. Asia Pacific Enzyme Toxicity Assays Market By Region, From 2018-2023 ( USD Million )
  8. Asia Pacific Receptor Binding Assays Market By Region, From 2018-2023 ( USD Million )
  9. Asia Pacific Bacterial Toxicity Assays Market By Region, From 2018-2023 ( USD Million )
  10. Asia Pacific Tissues Culture Assays Market By Region, From 2018-2023 ( USD Million )
  11. Asia Pacific Other Assays Market By Region, From 2018-2023 ( USD Million )
  12. Asia Pacific Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
  13. Asia Pacific Pharmaceutical Market By Region, From 2018-2023 ( USD Million )
  14. Asia Pacific Food and Beverages Market By Region, From 2018-2023 ( USD Million )
  15. Asia Pacific Chemical Industry Market By Region, From 2018-2023 ( USD Million )
  16. Asia Pacific Diagnostics Market By Region, From 2018-2023 ( USD Million )
  17. Asia Pacific Cosmetics Market By Region, From 2018-2023 ( USD Million )
  18. Asia Pacific Others Market By Region, From 2018-2023 ( USD Million )
  19. Japan Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  20. Japan Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  21. Japan Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
  22. China Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  23. China Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  24. China Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
  25. India Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  26. India Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  27. India Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
  28. Australia Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  29. Australia Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  30. Australia Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
  31. South Korea Early Toxicity Testing  Market By Technique, From 2018-2023 ( USD Million )
  32. South Korea Early Toxicity Testing  Market By Assays, From 2018-2023 ( USD Million )
  33. South Korea Early Toxicity Testing  Market By End-user, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.